{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:32:49Z","timestamp":1793039569644,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS124784"],"award-info":[{"award-number":["R01NS124784"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY029409"],"award-info":[{"award-number":["R01EY029409"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004948","name":"Michigan Economic Development Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jtos.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:27:37Z","timestamp":1746725257000},"page":"283-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The ocular surface tear film as a biomarker for systemic health"],"prefix":"10.1016","volume":"37","author":[{"given":"Navid","family":"Fotovat-Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8979-8319","authenticated-orcid":false,"given":"Omer","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanon","family":"Thanitcul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Cologna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3488-4583","authenticated-orcid":false,"given":"Vinay Kumar","family":"Aakalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2025.05.005_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision medicine, AI, and the future of Personalized health care","volume":"14","author":"Johnson","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jtos.2025.05.005_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.9.2.6","article-title":"Insights into systemic disease through retinal imaging-based oculomics","volume":"9","author":"Wagner","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2025.05.005_bib3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s40123-024-00942-x","article-title":"Oculomics: a crusade against the four horsemen of chronic disease","volume":"13","author":"Patterson","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2025.05.005_bib4","unstructured":"Apra-H. ARPA-H launches program to develop tear-based biomarker measurement platform. https:\/\/arpa-h.gov\/news-and-events\/arpa-h-launches-program-develop-tear-based-biomarker-measurement-platform (Accessed 3\/28\/25) n.d."},{"key":"10.1016\/j.jtos.2025.05.005_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2025.05.005_bib6","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ophtha.2021.03.030","article-title":"Systemic conditions associated with severity of dry eye signs and symptoms in the dry eye assessment and management (DREAM) study","volume":"128","author":"Yu","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2025.05.005_bib7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/biom13050724","article-title":"The autoimmune rheumatic disease related dry eye and its association with retinopathy","volume":"13","author":"Shan","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtos.2025.05.005_bib8","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.3390\/jcm9113740","article-title":"Impact of air pollution and weather on dry eye","volume":"9","author":"Mandell","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtos.2025.05.005_bib9","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4103\/IJO.IJO_2887_22","article-title":"Hormones and dry eye disease","volume":"71","author":"Gorimanipalli","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.005_bib10","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S0039-6257(00)00200-9","article-title":"The pathology of dry eye","volume":"45","author":"Baudouin","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.005_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2147\/OPTH.S210044","article-title":"An assessment of the ocular tear film in patients with thyroid disorders","volume":"13","author":"Alanazi","year":"2019","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"10.1016\/j.jtos.2025.05.005_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/srep33083","article-title":"Vitamin D supplementation for patients with dry eye syndrome refractory to conventional treatment","volume":"6","author":"Bae","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib13","doi-asserted-by":"crossref","unstructured":"K\u0131l\u0131\u00e7\u00e7\u0131o\u011flu A, Oncel D, Celebi ARC. Autoimmune Disease-Related Dry Eye Diseases and Their Placement Under the Revised Classification Systems: An Update. Cureus n.d.;15:e50276. https:\/\/doi.org\/10.7759\/cureus.50276.","DOI":"10.7759\/cureus.50276"},{"key":"10.1016\/j.jtos.2025.05.005_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","article-title":"Dysfunctional tear syndrome: dry eye disease and associated tear film disorders \u2013 new strategies for diagnosis and treatment","volume":"28","author":"Milner","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.005_bib15","first-page":"158","article-title":"Tear film disorders as a manifestation of various diseases and conditions","volume":"122","author":"Niezgoda","year":"2020","journal-title":"Klin Ocz Acta Ophthalmol Pol"},{"key":"10.1016\/j.jtos.2025.05.005_bib16","series-title":"StatPearls","article-title":"Meibomian gland disease","author":"Kaur","year":"2025"},{"key":"10.1016\/j.jtos.2025.05.005_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jtos.2020.04.003","article-title":"Systemic risk factors of dry eye disease subtypes: a New Zealand cross-sectional study","volume":"18","author":"Wang","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.05.005_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4331\/wjbc.v12.i5.57","article-title":"Proteomics: concepts and applications in human medicine","volume":"12","author":"Al-Amrani","year":"2021","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.jtos.2025.05.005_bib19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9440(10)63367-6","article-title":"Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections","volume":"165","author":"Chaurand","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2025.05.005_bib20","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/j.jprot.2012.04.053","article-title":"In-depth analysis of the human tear proteome","volume":"75","author":"Zhou","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/j.jtos.2025.05.005_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/02713688209000774","article-title":"Human tears: normal protein pattern and individual protein determinations in adults","volume":"2","author":"Gachon","year":"1982","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2025.05.005_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89514-8","article-title":"Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing","volume":"11","author":"Bachhuber","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ijmm.2021.4916","article-title":"Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases","volume":"47","author":"Ma","year":"2021","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jtos.2025.05.005_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700401","article-title":"Digging deep into peptidomics applied to body fluids","volume":"18","author":"Vitorino","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.jtos.2025.05.005_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.9.3.16","article-title":"Comparison of capillary and schirmer strip tear fluid sampling methods using SWATH-MS proteomics approach","volume":"9","author":"N\u00e4ttinen","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2025.05.005_bib26","first-page":"456","article-title":"Investigation of the human tear film proteome using multiple proteomic approaches","volume":"14","author":"Green-Church","year":"2008","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2025.05.005_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF00186580","article-title":"Collection and concentration of tear proteins studied by SDS gel electrophoresis Presentation of a new method with special reference to dry eye patients","volume":"232","author":"Bjerrum","year":"1994","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.005_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41598-023-28363-z","article-title":"Pre-analytical sample handling effects on tear fluid protein levels","volume":"13","author":"Gijs","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib29","doi-asserted-by":"crossref","first-page":"A.3A.1","DOI":"10.1002\/cpph.3","article-title":"Assays for determination of protein concentration","volume":"73","author":"Olson","year":"2016","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.jtos.2025.05.005_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102254","article-title":"Recent advances on protein separation and purification methods","volume":"284","author":"Liu","year":"2020","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.jtos.2025.05.005_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3803\/EnM.2017.32.1.18","article-title":"Simple outline of methods for protein isolation and purification","volume":"32","author":"Lee","year":"2017","journal-title":"Endocrinol Metab Seoul Korea"},{"key":"10.1016\/j.jtos.2025.05.005_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13167-021-00265-y","article-title":"Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine","volume":"12","author":"Zhan","year":"2021","journal-title":"EPMA J"},{"key":"10.1016\/j.jtos.2025.05.005_bib33","first-page":"205","article-title":"Quantification of proteins by iTRAQ","volume":"vol. 658","author":"Unwin","year":"2010"},{"key":"10.1016\/j.jtos.2025.05.005_bib34","first-page":"134","article-title":"Improved 2D nano-LC\/MS for proteomics applications: a comparative analysis using yeast proteome","volume":"15","author":"N\u00e4gele","year":"2004","journal-title":"J Biomol Tech JBT"},{"key":"10.1016\/j.jtos.2025.05.005_bib35","first-page":"4404","article-title":"Nano-liquid chromatography-mass spectrometry and recent applications in omics investigations","volume":"12","author":"Sanders","year":"2020","journal-title":"Anal Methods Adv Methods Appl"},{"key":"10.1016\/j.jtos.2025.05.005_bib36","first-page":"233","article-title":"Proteomic approaches by SELDI and MALDI-TOF\/MS for CTL analysis","volume":"vol. 1186","author":"Papale","year":"2014"},{"key":"10.1016\/j.jtos.2025.05.005_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cbpa.2008.07.024","article-title":"Mass spectrometry for proteomics","volume":"12","author":"Han","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jtos.2025.05.005_bib38","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1021\/pr0501970","article-title":"Characterization of human tear proteome using multiple proteomic analysis techniques","volume":"4","author":"Li","year":"2005","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jtos.2025.05.005_bib39","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/gb-2006-7-8-r72","article-title":"Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors","volume":"7","author":"de Souza","year":"2006","journal-title":"Genome Biol"},{"key":"10.1016\/j.jtos.2025.05.005_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of early Alzheimer's disease: clinical practice in 2021","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.jtos.2025.05.005_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01993-x","article-title":"Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration","volume":"11","author":"Gijs","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib42","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.3390\/ijms24032590","article-title":"Beta-amyloid peptide in tears: an early diagnostic marker of Alzheimer's disease correlated with choroidal thickness","volume":"24","author":"Gharbiya","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.05.005_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158000","article-title":"Changes in the chemical barrier composition of tears in Alzheimer's disease reveal potential tear diagnostic biomarkers","volume":"11","author":"Kall\u00f3","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2025.05.005_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51837-y","article-title":"Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer's disease","volume":"9","author":"Kenny","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib45","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1038\/s41467-023-43995-5","article-title":"Amplified fluorogenic immunoassay for early diagnosis and monitoring of Alzheimer's disease from tear fluid","volume":"14","author":"Lee","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtos.2025.05.005_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13195-024-01556-y","article-title":"Neurodegenerative biomarkers in different chambers of the eye relative to plasma: an agreement validation study","volume":"16","author":"Sampani","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jtos.2025.05.005_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106730","article-title":"Linking human cerebral and ocular waste clearance: insights from tear fluid and ultra-high field MRI","volume":"203","author":"van der Thiel","year":"2024","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jtos.2025.05.005_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267676","article-title":"Using tears as a non-invasive source for early detection of breast cancer","volume":"17","author":"Daily","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2025.05.005_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.critrevonc.2014.10.002","article-title":"Evaluation of serum-based cancer biomarkers: a brief review from a clinical and computational viewpoint","volume":"93","author":"Yotsukura","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jtos.2025.05.005_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1442-9071.2001.00408.x","article-title":"Lacryglobin in human tears, a potential marker for cancer","volume":"29","author":"Evans","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.005_bib51","first-page":"75","article-title":"Surface-enhanced laser desorption\/ionisation time-of-flight mass spectrometry to detect breast cancer markers in tears and serum","volume":"6","author":"Lebrecht","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.jtos.2025.05.005_bib52","first-page":"177","article-title":"Diagnosis of breast cancer by tear proteomic pattern","volume":"6","author":"Lebrecht","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.jtos.2025.05.005_bib53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/or.2012.1849","article-title":"Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach","volume":"28","author":"B\u00f6hm","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib54","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.21873\/anticanres.14290","article-title":"Oncogenic miRNAs identified in tear exosomes from metastatic breast cancer patients","volume":"40","author":"Inubushi","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jtos.2025.05.005_bib55","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/cancers12082037","article-title":"Friend or foe: S100 proteins in cancer","volume":"12","author":"Allg\u00f6wer","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jtos.2025.05.005_bib56","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-013-2737-1","article-title":"RAGE-binding S100A8\/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition","volume":"142","author":"Yin","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jtos.2025.05.005_bib57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40364-022-00420-1","article-title":"Development and validation of a short-term breast health measure as a supplement to screening mammography","volume":"10","author":"Daily","year":"2022","journal-title":"Biomark Res"},{"key":"10.1016\/j.jtos.2025.05.005_bib58","first-page":"1396","article-title":"Tear cytokine profiles in patients with extranodal marginal zone B-cell lymphoma of the ocular adnexa","volume":"36","author":"Xiao","year":"2022","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.jtos.2025.05.005_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjsurg.2022.03.029","article-title":"Proteomic profiling of tear fluid as a promising non-invasive screening test for colon cancer","volume":"224","author":"Kaufmann","year":"2022","journal-title":"Am J Surg"},{"key":"10.1016\/j.jtos.2025.05.005_bib60","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.3390\/ijms23073714","article-title":"Proteomic profiling of saliva and tears in radiated head and neck cancer patients as compared to primary Sj\u00f6gren\u2019s syndrome patients","volume":"23","author":"Hynne","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.05.005_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.608821","article-title":"Early diagnosis and intervention in cystic fibrosis: imagining the unimaginable","volume":"8","author":"Coverstone","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtos.2025.05.005_bib62","series-title":"Cystic fibrosis. StatPearls","author":"Yu","year":"2025"},{"key":"10.1016\/j.jtos.2025.05.005_bib63","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/bmj.39391.713229.AD","article-title":"Cystic fibrosis","volume":"335","author":"Davies","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jtos.2025.05.005_bib64","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.3390\/ijms25126692","article-title":"Ocular changes in cystic fibrosis: a review","volume":"25","author":"Liberski","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.05.005_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/pir.2019-0212","article-title":"Cystic fibrosis","volume":"42","author":"Dickinson","year":"2021","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.jtos.2025.05.005_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/jir.2006.26.71","article-title":"IL-8 and IFN-gamma in tear fluid of patients with cystic fibrosis","volume":"26","author":"Mrugacz","year":"2006","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"10.1016\/j.jtos.2025.05.005_bib67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11916-011-0233-z","article-title":"Defining the differences between episodic migraine and chronic migraine","volume":"16","author":"Katsarava","year":"2012","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib68","doi-asserted-by":"crossref","first-page":"800605","DOI":"10.3389\/fneur.2021.800605","article-title":"Migraine: a review on its history, global epidemiology, risk factors, and comorbidities","volume":"12","author":"Amiri","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.jtos.2025.05.005_bib69","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1177\/0333102419856640","article-title":"Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls","volume":"39","author":"Kamm","year":"2019","journal-title":"Cephalalgia Int J Headache"},{"key":"10.1016\/j.jtos.2025.05.005_bib70","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jtos.2025.05.005_bib71","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1007\/s00415-020-09964-4","article-title":"Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers","volume":"268","author":"Ferrazzano","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.jtos.2025.05.005_bib72","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3389\/fimmu.2019.01110","article-title":"Investigation of oligoclonal IgG bands in tear fluid of multiple sclerosis patients","volume":"10","author":"H\u00fcmmert","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2025.05.005_bib73","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/01616412.2024.2337502","article-title":"The level of cytokines in tears as a novel indicator of demyelinating diseases","volume":"46","author":"Adamczyk-Zostawa","year":"2024","journal-title":"Neurol Res"},{"key":"10.1016\/j.jtos.2025.05.005_bib74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/prca.201300053","article-title":"Exploring the human tear fluid: D iscovery of new biomarkers in multiple sclerosis","volume":"8","author":"Salvisberg","year":"2014","journal-title":"PROTEOMICS \u2013 Clin Appl"},{"key":"10.1016\/j.jtos.2025.05.005_bib75","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/ijms20061265","article-title":"Integrated lipidomics and metabolomics analysis of tears in multiple sclerosis: an insight into diagnostic potential of lacrimal fluid","volume":"20","author":"Cicalini","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.05.005_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cen.14296","article-title":"Prevalence of thyroid eye disease in Graves' disease: a meta-analysis and systematic review","volume":"93","author":"Chin","year":"2020","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jtos.2025.05.005_bib77","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/jc.2016-1220","article-title":"Thyroid stimulating antibodies are highly prevalent in Hashimoto's thyroiditis and associated orbitopathy","volume":"101","author":"Kahaly","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtos.2025.05.005_bib78","first-page":"343","article-title":"Thyroid eye disease","volume":"119","author":"Szelog","year":"2022","journal-title":"Mo Med"},{"key":"10.1016\/j.jtos.2025.05.005_bib79","series-title":"StatPearls","article-title":"Thyroid eye disease","author":"Shah","year":"2025"},{"key":"10.1016\/j.jtos.2025.05.005_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35096-x","article-title":"Tear proteins calcium binding protein A4 (S100A4) and prolactin induced protein (PIP) are potential biomarkers for thyroid eye disease","volume":"8","author":"Chng","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib81","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jprot.2017.09.001","article-title":"Thyroid-associated orbitopathy and tears: a proteomics study","volume":"170","author":"Kishazi","year":"2018","journal-title":"J Proteomics"},{"key":"10.1016\/j.jtos.2025.05.005_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29113-2","article-title":"Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy","volume":"8","author":"Kishazi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib83","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1167\/iovs.15-16699","article-title":"Proteomics differentiate between thyroid-associated orbitopathy and dry eye syndrome","volume":"56","author":"Matheis","year":"2015","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.jtos.2025.05.005_bib84","first-page":"1","article-title":"Role of biomarkers in south Indian thyroid eye disease study (SITED)","author":"Nivean","year":"2025","journal-title":"Orbit"},{"key":"10.1016\/j.jtos.2025.05.005_bib85","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-0029-1214413","article-title":"Proteomics in autoimmune thyroid eye disease","volume":"41","author":"Okrojek","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jtos.2025.05.005_bib86","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1167\/iovs.13-13704","article-title":"Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy","volume":"55","author":"Huang","year":"2014","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.jtos.2025.05.005_bib87","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00417-017-3892-6","article-title":"The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis","volume":"256","author":"Mandi\u0107","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.005_bib88","first-page":"291","article-title":"Proteomics of tear in inactive thyroid-associated ophthalmopathy","volume":"17","author":"Jiang","year":"2021","journal-title":"Acta Endocrinol Buchar"},{"key":"10.1016\/j.jtos.2025.05.005_bib89","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/thy.2011.0248","article-title":"Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines","volume":"22","author":"Ujhelyi","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.jtos.2025.05.005_bib90","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/jcm11020404","article-title":"A tear metabolomic profile showing increased ornithine decarboxylase activity and spermine synthesis in thyroid-associated orbitopathy","volume":"11","author":"Billiet","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtos.2025.05.005_bib91","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"1996","journal-title":"J Neural Transm Vienna Austria"},{"key":"10.1016\/j.jtos.2025.05.005_bib92","first-page":"15","article-title":"Current and projected future economic burden of Parkinson's disease in the U.S. NPJ Park","volume":"6","author":"Yang","year":"2020","journal-title":"Dis"},{"key":"10.1016\/j.jtos.2025.05.005_bib93","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/mds.27110","article-title":"Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson's disease: a systematic review and meta-analysis","volume":"32","author":"Eusebi","year":"2017","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.jtos.2025.05.005_bib94","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2217\/bmm-2019-0315","article-title":"Levels of oligomeric \u03b1-Synuclein in reflex tears distinguish Parkinson's disease patients from healthy controls","volume":"13","author":"Hamm-Alvarez","year":"2019","journal-title":"Biomark Med"},{"key":"10.1016\/j.jtos.2025.05.005_bib95","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.1038\/s41598-020-65503-1","article-title":"Increased alpha-synuclein tear fluid levels in patients with Parkinson's disease","volume":"10","author":"Maass","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib96","doi-asserted-by":"crossref","first-page":"S10.001","DOI":"10.1212\/WNL.92.15_supplement.S10.001","article-title":"Identifying biomarkers for Parkinson's disease with reflex tears (S10.001)","volume":"92","author":"Lew","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jtos.2025.05.005_bib97","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1212\/WNL.98.18_supplement.3750","article-title":"Biomarkers for Parkinson's disease with reflex tears stratified by disease duration (S16.002)","volume":"98","author":"Lew","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jtos.2025.05.005_bib98","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s11357-022-00576-6","article-title":"Elevated \u03b1-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease","volume":"44","author":"Lin","year":"2022","journal-title":"GeroScience"},{"key":"10.1016\/j.jtos.2025.05.005_bib99","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/11206721231173725","article-title":"Is there any correlation between alpha-synuclein levels in tears and retinal layer thickness in Parkinson's disease?","volume":"34","author":"Camacho-Ordonez","year":"2024","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.005_bib100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jtos.2025.05.005_bib101","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2013.08.019","article-title":"Tear levels of tumor necrosis factor-alpha in patients with Parkinson's disease","volume":"553","author":"\u00c7omo\u011flu","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jtos.2025.05.005_bib102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.32607\/20758251-2019-11-4-99-103","article-title":"Tear fluid catecholamines as biomarkers of the Parkinson's disease: a clinical and experimental study","volume":"11","author":"Kim","year":"2019","journal-title":"Acta Naturae"},{"key":"10.1016\/j.jtos.2025.05.005_bib103","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.3390\/ijms22094736","article-title":"A pilot study of changes in the level of catecholamines and the activity of \u03b1-2-macroglobulin in the tear fluid of patients with Parkinson's disease and parkinsonian mice","volume":"22","author":"Bogdanov","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.05.005_bib104","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1038\/s41598-024-54800-8","article-title":"Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson's disease","volume":"14","author":"Tatenhorst","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.03.001","article-title":"Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - a pilot study","volume":"63","author":"Boerger","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jtos.2025.05.005_bib106","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/proteomes10010004","article-title":"Potential tear biomarkers for the diagnosis of Parkinson's disease-A pilot study","volume":"10","author":"Acera","year":"2022","journal-title":"Proteomes"},{"key":"10.1016\/j.jtos.2025.05.005_bib107","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1212\/WNL.0000000000202879","article-title":"Tear fluid as a biomarker for Parkinson's disease: downregulation of DNA repair genes\/pathways via RNA-seq analysis (S37.007)","volume":"100","author":"Lew","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jtos.2025.05.005_bib108","first-page":"20","article-title":"Meibum lipid composition and conformation in parkinsonism","volume":"12","author":"Blinchevsky","year":"2021","journal-title":"EC Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.005_bib109","series-title":"Sjogren syndrome. StatPearls, treasure island (FL)","author":"Carsons","year":"2025"},{"key":"10.1016\/j.jtos.2025.05.005_bib110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/25785826.2020.1729597","article-title":"Dry eye in rheumatoid arthritis: relation to disease activity","volume":"43","author":"Abd-Allah","year":"2020","journal-title":"Immunol Med"},{"key":"10.1016\/j.jtos.2025.05.005_bib111","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of sj\u00f6gren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtos.2025.05.005_bib112","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtos.2016.09.005","article-title":"Tear fluid protein changes in dry eye syndrome associated with rheumatoid arthritis: a proteomic approach","volume":"15","author":"Aluru","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.05.005_bib113","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3390\/cimb45040188","article-title":"A pilot study of a panel of ocular inflammation biomarkers in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"45","author":"Boto De Los Bueis","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.jtos.2025.05.005_bib114","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29411-9","article-title":"Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sj\u00f6gren\u2019s Syndrome patients","volume":"8","author":"Edman","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.05.005_bib115","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/art.38633","article-title":"Tear cathepsin S as a candidate biomarker for Sj\u00f6gren\u2019s syndrome","volume":"66","author":"Hamm\u2010Alvarez","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtos.2025.05.005_bib116","series-title":"Tear proteomic profiling as potential non-invasive laboratory test for rheumatoid arthritis","author":"Sariri","year":"2010"},{"key":"10.1016\/j.jtos.2025.05.005_bib117","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.85.2.147","article-title":"Tear film MMP accumulation and corneal disease","volume":"85","author":"Smith","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.005_bib118","unstructured":"Yavuz S, Toker E, Bicakcigil M, Mumcu G, Cakir S. Comparative analysis of autoantibodies against \u03b1-fodrin in serum, tear fluid, and saliva from patients with Sj\u00f6gren\u2019s syndrome n.d."}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:12:13Z","timestamp":1778818333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012425000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":118,"alternative-id":["S1542012425000667"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2025.05.005","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ocular surface tear film as a biomarker for systemic health","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}